WebDisclosure WebDisclosure
Basculer en Français
11165 Companies
246594 Keywords
174534 Articles
133176 Press releases
Headlines Articles Press releases PL BioScience GmbH Remove
  1. Home
  2. Companies
  3. PL BioScience GmbH
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/30/2025 at 12:05, 1 year 5 months ago

    PL BioScience Unveils Unique Gamma-irradiated Human Platelet Lysate

    Regenerative Medicine Cell Therapy Human Platelet Lysate Gamma-Irradiation Xeno-Free Supplement
  • BRIEF

    published on 04/30/2025 at 12:05, 1 year 5 months ago

    PL BioScience dévoile un lysat plaquettaire humain unique irradié aux rayons gamma

    Médecine Régénérative Thérapie Cellulaire Lysat Plaquettaire Humain Irradiation Gamma Supplément Sans Xénobiotiques
  • PRESS RELEASE

    published on 04/30/2025 at 12:00, 1 year 5 months ago

    PL BioScience Launches World’s Only Patented Gamma-irradiated Human Platelet Lysate

    PL BioScience launches ELAREM™ Ultimate-FD PLUS, the only gamma-irradiated, GMP-grade Human Platelet Lysate in Europe. The product offers a safer, sustainable, virus-inactivated, and animal-free alternative for cell manufacturing applications
    GMP-grade Human Platelet Lysate PL BioScience ELAREM Ultimate-FD PLUS Gamma-irradiated
    Logo of PL BioScience GmbH
Previous page
1 ... 3 4
Accesswire
  • Published on 10/13/2026 at 14:45, 25 minutes ago

    Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides

  • Published on 10/13/2026 at 14:31, 39 minutes ago

    First Breach Completes First Autonomous Flight of Proprietary Drone Prototype

  • Published on 10/13/2026 at 14:10, 1 hour ago

    NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements

  • Published on 10/13/2026 at 14:00, 1 hour 10 minutes ago

    Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold

  • Published on 10/13/2026 at 14:00, 1 hour 10 minutes ago

    Fermi Signs Credit Support Agreement with AMD and Announces Partnership

View all ACCESSWIRE
EQS Group
  • Published on 10/13/2026 at 14:53, 16 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

  • Published on 10/13/2026 at 14:53, 16 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Vesuvius plc

  • Published on 10/13/2026 at 14:52, 17 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: easyJet plc

  • Published on 10/13/2026 at 14:51, 18 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: SEGRO plc

  • Published on 10/13/2026 at 14:51, 18 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Bodycote plc

View all EQS
Les Echos
  • Published on 10/13/2026 at 12:31, 2 hours 38 minutes ago

    Il Perù è riconosciuto come "Migliore destinazione del Sud America" ai World Travel Awards

  • Published on 10/13/2026 at 12:29, 2 hours 40 minutes ago

    Le Pérou est reconnu comme la « Meilleure destination d'Amérique du Sud » aux World Travel Awards

  • Published on 10/13/2026 at 09:04, 6 hours 5 minutes ago

    Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards

  • Published on 10/12/2026 at 17:59, 21 hours 10 minutes ago

    Reporting on share buyback transactions carried out between October 7 and October 9, 2026

  • Published on 10/12/2026 at 17:59, 21 hours 10 minutes ago

    Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 7 au 9 octobre 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy